United States · FDA National Drug Code directory

DOXORUBICIN HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70748-340_e9f76142-15d0-4234-8f2e-5f5014160eff
Product NDC: 70748-340
Form: INJECTION, SUSPENSION, LIPOSOMAL
Composition / generic term: DOXORUBICIN HYDROCHLORIDE
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20240826
Source listing expiry: 20261231

Source-listed ingredients

DOXORUBICIN HYDROCHLORIDE — 2 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL, SINGLE-USE in 1 CARTON (70748-340-01) / 25 mL in 1 VIAL, SINGLE-USE · 70748-340-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →